Baxter International (BTL) Stock Forecast & Price Target

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BTL Analyst Ratings

Hold

0 Buy

9 Hold

1 Sell

Based on 10 analysts giving stock ratings to

Baxter

International

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BTL Stock 12 Month Forecast

Average Price Target

€22.66

▲(2.78% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Baxter International in the last 3 months. The average price target is €22.66 with a high forecast of €25.87 and a low forecast of €17.84. The average price target represents a 2.78% change from the last price of €22.05.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"13":"€13","26":"€26","16.25":"€16.25","19.5":"€19.5","22.75":"€22.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25.87437536,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€25.87</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22.662383936,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€22.66</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.8443968,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€17.84</span>\n  </div></div>","useHTML":true}}],"tickPositions":[13,16.25,19.5,22.75,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.86,21.24572118153846,21.63144236307692,22.017163544615386,22.402884726153847,22.788605907692308,23.17432708923077,23.56004827076923,23.94576945230769,24.33149063384615,24.717211815384616,25.102932996923077,25.488654178461537,{"y":25.87437536,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.86,20.998644918153847,21.13728983630769,21.275934754461538,21.414579672615385,21.55322459076923,21.691869508923077,21.830514427076924,21.96915934523077,22.107804263384615,22.246449181538463,22.38509409969231,22.523739017846154,{"y":22.662383936,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.86,20.628030523076923,20.396061046153847,20.16409156923077,19.93212209230769,19.700152615384614,19.468183138461537,19.23621366153846,19.004244184615384,18.772274707692308,18.540305230769228,18.30833575384615,18.076366276923075,{"y":17.8443968,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.918,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.076,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.713,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.065,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.618,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.73,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.232,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.716,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.713,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.322,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.931,"date":1785542400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":22.09,"date":1788220800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":20.86,"date":1790812800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€25.87

Average Price Target€22.66

Lowest Price Target€17.84

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Christopher Pasquale

Barclays

€17.84

Sell

-19.07%

Downside

Initiated

10/07/26

Barclays Reaffirms Their Sell Rating on Baxter International (BAX)

Joanne Wuensch

Citi

€24.98→€24.09

Hold

9.25%

Upside

Reiterated

10/05/26

Baxter price target lowered to $27 from $28 at CitiBaxter price target lowered to $27 from $28 at Citi

Travis Steed

Bank of America Securities

€17.84→€24.98

Hold

13.30%

Upside

Reiterated

08/11/26

Bank of America Securities Sticks to Its Hold Rating for Baxter International (BAX)

Robbie Marcus

J.P. Morgan

€23.2

Hold

5.21%

Upside

Reiterated

08/06/26

J.P. Morgan Sticks to Their Hold Rating for Baxter International (BAX)

Unknown Analyst

Wells Fargo

Not Ranked

Wells Fargo

€16.95→€20.52

Hold

-6.93%

Downside

Assigned

07/31/26

Baxter International (BAX) Gets a Hold from Wells Fargo

Pito Chickering

Deutsche Bank

€17.84→€24.09

Hold

9.25%

Upside

Reiterated

07/31/26

Baxter price target raised to $27 from $20 at Deutsche BankBaxter price target raised to $27 from $20 at Deutsche Bank

Josh Jennings

TD Cowen

€21.41→€25.87

Hold

17.34%

Upside

Reiterated

07/31/26

Analysts Conflicted on These Healthcare Names: Karyopharm Therapeutics (NASDAQ: KPTI), Baxter International (NYSE: BAX) and Alnylam Pharma (NASDAQ: ALNY)

Rick Wise

Stifel Nicolaus

€21.41→€24.98

Hold

13.30%

Upside

Reiterated

07/31/26

Baxter price target raised to $24 from $19 at StifelBaxter price target raised to $24 from $19 at Stifel

Patrick Wood

UBS

€16.95→€22.31

Hold

1.16%

Upside

Assigned

07/28/26

Analysts Conflicted on These Healthcare Names: Baxter International (NYSE: BAX), Incyte (NASDAQ: INCY) and Argenx Se (NASDAQ: ARGX)

David Roman

Goldman Sachs

€16.95→€18.74

Hold

-15.03%

Downside

Assigned

07/15/26

Baxter price target raised to $21 from $19 at Goldman SachsBaxter price target raised to $21 from $19 at Goldman Sachs

Vijay Kumar

Evercore ISI

€19.63→€21.41

Buy

-2.89%

Downside

Reiterated

07/06/26

Baxter price target raised to $24 from $22 at Evercore ISIBaxter price target raised to $24 from $22 at Evercore ISI

Steven Silver

Argus Research

―

Hold

―

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Baxter International (NYSE: BAX) and Capricor Therapeutics (NASDAQ: CAPR)

Matthew Taylor

Jefferies

€18.74→€16.95

Hold

-23.12%

Downside

Reiterated

02/12/26

Baxter price target lowered to $19 from $21 at JefferiesBaxter price target lowered to $19 from $21 at Jefferies

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Christopher Pasquale

Barclays

€17.84

Sell

-19.07%

Downside

Initiated

10/07/26

Barclays Reaffirms Their Sell Rating on Baxter International (BAX)

Joanne Wuensch

Citi

€24.98→€24.09

Hold

9.25%

Upside

Reiterated

10/05/26

Baxter price target lowered to $27 from $28 at CitiBaxter price target lowered to $27 from $28 at Citi

Travis Steed

Bank of America Securities

€17.84→€24.98

Hold

13.30%

Upside

Reiterated

08/11/26

Bank of America Securities Sticks to Its Hold Rating for Baxter International (BAX)

Robbie Marcus

J.P. Morgan

€23.2

Hold

5.21%

Upside

Reiterated

08/06/26

J.P. Morgan Sticks to Their Hold Rating for Baxter International (BAX)

Unknown Analyst

Wells Fargo

Not Ranked

Wells Fargo

€16.95→€20.52

Hold

-6.93%

Downside

Assigned

07/31/26

Baxter International (BAX) Gets a Hold from Wells Fargo

Pito Chickering

Deutsche Bank

€17.84→€24.09

Hold

9.25%

Upside

Reiterated

07/31/26

Baxter price target raised to $27 from $20 at Deutsche BankBaxter price target raised to $27 from $20 at Deutsche Bank

Josh Jennings

TD Cowen

€21.41→€25.87

Hold

17.34%

Upside

Reiterated

07/31/26

Analysts Conflicted on These Healthcare Names: Karyopharm Therapeutics (NASDAQ: KPTI), Baxter International (NYSE: BAX) and Alnylam Pharma (NASDAQ: ALNY)

Rick Wise

Stifel Nicolaus

€21.41→€24.98

Hold

13.30%

Upside

Reiterated

07/31/26

Baxter price target raised to $24 from $19 at StifelBaxter price target raised to $24 from $19 at Stifel

Patrick Wood

UBS

€16.95→€22.31

Hold

1.16%

Upside

Assigned

07/28/26

Analysts Conflicted on These Healthcare Names: Baxter International (NYSE: BAX), Incyte (NASDAQ: INCY) and Argenx Se (NASDAQ: ARGX)

David Roman

Goldman Sachs

€16.95→€18.74

Hold

-15.03%

Downside

Assigned

07/15/26

Baxter price target raised to $21 from $19 at Goldman SachsBaxter price target raised to $21 from $19 at Goldman Sachs

Vijay Kumar

Evercore ISI

€19.63→€21.41

Buy

-2.89%

Downside

Reiterated

07/06/26

Baxter price target raised to $24 from $22 at Evercore ISIBaxter price target raised to $24 from $22 at Evercore ISI

Steven Silver

Argus Research

―

Hold

―

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Baxter International (NYSE: BAX) and Capricor Therapeutics (NASDAQ: CAPR)

Matthew Taylor

Jefferies

€18.74→€16.95

Hold

-23.12%

Downside

Reiterated

02/12/26

Baxter price target lowered to $19 from $21 at JefferiesBaxter price target lowered to $19 from $21 at Jefferies

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ONCBeOne Medicines

HELPHelus Pharma

ARDXArdelyx

CELCCelcuity

OMCLOmnicell

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Baxter International

3 Months

Vijay KumarEvercore ISI

Success Rate

8/19 ratings generated profit

Average Return

-1.24%

Copying Vijay Kumar's trades and holding each position for 3 Months would result in 42.11% of your transactions generating a profit, with an average return of -1.24% per trade.

1 Year

Vijay KumarEvercore ISI

Success Rate

9/19 ratings generated profit

Average Return

-4.11%

Copying Vijay Kumar's trades and holding each position for 1 Year would result in 47.37% of your transactions generating a profit, with an average return of -4.11% per trade.

2 Years

Vijay KumarEvercore ISI

Success Rate

8/19 ratings generated profit

Average Return

-5.67%

Copying Vijay Kumar's trades and holding each position for 2 Years would result in 42.11% of your transactions generating a profit, with an average return of -5.67% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BTL Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BTL has received 0 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. BTL average Analyst price target in the past 3 months is 22.66.

Each month's total comprises the sum of three months' worth of ratings.

BTL Financial Forecast

BTL Earnings Forecast

Next quarter’s earnings estimate for BTL is €0.46 with a range of €0.45 to €0.48. The previous quarter’s EPS was €0.50. BTL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BTL has Performed in-line its overall industry.

BTL Sales Forecast

Next quarter’s sales forecast for BTL is €2.60B with a range of €2.57B to €2.61B. The previous quarter’s sales results were €2.64B. BTL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BTL has Performed in-line its overall industry.

BTL Stock Forecast FAQ

What is DE:BTL’s average 12-month price target, according to analysts?

Based on analyst ratings, Baxter International’s 12-month average price target is 22.66.

What is DE:BTL’s upside potential, based on the analysts’ average price target?

Baxter International has 2.78% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Baxter International a Buy, Sell or Hold?

Baxter International has a consensus rating of Hold, which is based on 0 buy ratings, 9 hold ratings and 1 sell ratings.

What is Baxter International’s share price target?

The average share price target for Baxter International is 22.66. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €25.87 ,and the lowest forecast is €17.84. The average share price target represents 2.78% Increase from the current price of €22.05.

What do analysts say about Baxter International?

Baxter International’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Baxter International?

To buy shares of DE:BTL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Baxter International (BTL) Stock Forecast & Price Target

BTL Analyst Ratings

BTL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Baxter International

BTL Analyst Recommendation Trends

BTL Financial Forecast

BTL Earnings Forecast

BTL Sales Forecast

BTL Stock Forecast FAQ

Detailed List of Analyst Forecasts